BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10441105)

  • 1. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat.
    Ruef J; Meshel AS; Hu Z; Horaist C; Ballinger CA; Thompson LJ; Subbarao VD; Dumont JA; Patterson C
    Circulation; 1999 Aug; 100(6):659-65. PubMed ID: 10441105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.
    Wang W; Chen HJ; Schwartz A; Cannon PJ; Stein CA; Rabbani LE
    J Clin Invest; 1996 Jul; 98(2):443-50. PubMed ID: 8755655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
    Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
    Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
    Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery.
    Izumi Y; Kim S; Namba M; Yasumoto H; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Zhan Y; Iwao H
    Circ Res; 2001 Jun; 88(11):1120-6. PubMed ID: 11397777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
    Yue TL; Vickery-Clark L; Louden CS; Gu JL; Ma XL; Narayanan PK; Li X; Chen J; Storer B; Willette R; Gossett KA; Ohlstein EH
    Circulation; 2000 Nov; 102(19 Suppl 3):III281-8. PubMed ID: 11082402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epothilone B inhibits neointimal formation after rat carotid injury through the regulation of cell cycle-related proteins.
    Lim Y; Kim TJ; Jin YR; Kim DW; Kwon JS; Son JH; Jung JC; Avery MA; Son DJ; Hong JT; Yun YP
    J Pharmacol Exp Ther; 2007 May; 321(2):648-55. PubMed ID: 17289837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
    Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
    Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
    Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.
    Chang MW; Barr E; Lu MM; Barton K; Leiden JM
    J Clin Invest; 1995 Nov; 96(5):2260-8. PubMed ID: 7593612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine inhibited nuclear factor-kappaB expression and the intimal hyperplasia in rat carotid arterial injury.
    Hayashi K; Takahata H; Kitagawa N; Kitange G; Kaminogo M; Shibata S
    Neurol Res; 2001 Oct; 23(7):731-8. PubMed ID: 11680513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins.
    Kim TJ; Lim Y; Kim DW; Kwon JS; Son JH; Jin YR; Son DJ; Jung JC; Avery MA; Hong JT; Yun YP
    Vascul Pharmacol; 2007 Oct; 47(4):229-37. PubMed ID: 17706465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.
    Tsihlis ND; Murar J; Kapadia MR; Ahanchi SS; Oustwani CS; Saavedra JE; Keefer LK; Kibbe MR
    J Vasc Surg; 2010 May; 51(5):1248-59. PubMed ID: 20223627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.
    Zuckerbraun BS; McCloskey CA; Mahidhara RS; Kim PK; Taylor BS; Tzeng E
    J Vasc Surg; 2003 Oct; 38(4):812-9. PubMed ID: 14560235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tas-301, a new synthetic inhibitor of neointimal thickening after balloon injury, inhibits calcium-dependent signal transduction and cytoskeletal reorganization.
    Sasaki E; Miyoshi K; Nozawa Y; Kanda A; Nakano K; Yamasaki Y; Miyake H; Matsuura N
    Pharmacology; 2001 Jul; 63(1):17-27. PubMed ID: 11408828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of interleukin-1 receptor-associated kinase-1 in vascular smooth muscle cell proliferation and neointimal formation after rat carotid injury.
    Jain M; Singh A; Singh V; Barthwal MK
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1445-55. PubMed ID: 25908764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.